Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?

Oncotarget. 2023 Jun 12:14:595-596. doi: 10.18632/oncotarget.28438.
No abstract available

Keywords: MEK inhibitor; RAD51AP1-DYRK4; chimerical transcript; luminal B breast cancer.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast
  • Breast Neoplasms*
  • Female
  • Humans